Skip to content

Muscle Oxygenation and Autonomic Recovery After Repeated Sprint in Competitive Soccer Players

Muscle Oxygenation and Autonomic Recovery After Repeated Sprint in Competitive Soccer Players: A NIRS-HRV-Based Field Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07742163
Enrollment
48
Registered
2026-08-03
Start date
2026-06-02
Completion date
2026-06-28
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise-Induced Fatigue

Keywords

Repeated Sprint, Muscle Oxygenation, Near-Infrared Spectroscopy, Heart Rate Variability, Countermovement Jump, Exercise Recovery, Soccer, Blood Lactate, Neuromuscular Performance

Brief summary

This study evaluates the acute and short-term recovery responses to repeated sprint exercise in competitive male soccer players. Forty-eight licensed male soccer players complete an 8 × 30 m repeated sprint protocol under field conditions, with 25 seconds of active recovery between sprints. The study examines several aspects of recovery. Muscle oxygenation is assessed using portable near-infrared spectroscopy sensors placed on the vastus lateralis and biceps femoris muscles. Cardiac autonomic recovery is evaluated using heart rate variability measurements obtained at baseline, 5 minutes, 30 minutes, and 24 hours after the repeated sprint protocol. Countermovement jump performance is measured before the protocol, 10 minutes after the protocol, and 24 hours later. Sprint performance, blood lactate concentration, and perceived exertion are also recorded to characterize the physiological and performance demands of the repeated sprint protocol. The study aims to determine how muscle oxygenation, cardiac autonomic recovery, and neuromuscular performance change during the recovery period following repeated sprint exercise and whether these recovery indicators are associated with repeated sprint performance.

Detailed description

This study uses a single-group repeated-measures design to investigate muscle oxygenation, cardiac autonomic recovery, and neuromuscular performance responses following repeated sprint exercise in competitive male soccer players. A total of 48 licensed male soccer players participate in the study. Participants regularly train and compete in soccer and have at least four years of soccer training experience. During the measurement session, demographic and anthropometric characteristics are recorded first. Baseline measurements include heart rate variability, muscle oxygen saturation, blood lactate concentration, and countermovement jump performance. After a standardized 10-minute warm-up, participants complete an 8 × 30 m repeated sprint protocol. Each sprint is performed with maximal effort, and a 25-second active/light jogging recovery period is provided between sprints. Sprint times are recorded using an electronic timing gate system. Muscle oxygenation is continuously assessed using portable near-infrared spectroscopy sensors placed on the vastus lateralis and biceps femoris muscles of the dominant leg. The evaluated muscle oxygenation variables include baseline muscle oxygen saturation, minimum muscle oxygen saturation, desaturation difference, 30-second reoxygenation muscle oxygen saturation, and reoxygenation rate. Cardiac autonomic recovery is evaluated using heart rate variability derived from R-R interval recordings obtained with a Polar H10 chest strap. Five-minute HRV recordings are obtained at baseline, 5 minutes after the repeated sprint protocol, 30 minutes after the protocol, and 24 hours after the protocol. RMSSD and SDNN are used as the primary time-domain HRV parameters. Neuromuscular performance is evaluated using countermovement jump height before the repeated sprint protocol, 10 minutes after the protocol, and 24 hours after the protocol. Blood lactate concentration is measured before the protocol and at 3 minutes after the protocol. Rating of perceived exertion is recorded after completion of the sprint protocol using the Borg CR10 scale. The study is designed to characterize the time course of recovery following repeated sprint exercise and to examine relationships among sprint performance, muscle oxygenation, cardiac autonomic recovery, and neuromuscular performance. Because the study uses a single-group design without a control group, the findings are interpreted as recovery-related associations rather than evidence of causal effects.

Interventions

OTHER8 x 30 m Repeated Sprint Exercise

Participants perform eight 30-m maximal sprints under field conditions. A 25-second active recovery period consisting of light jogging is provided between consecutive sprints. Before the repeated sprint protocol, participants complete a standardized 10-minute warm-up consisting of low-intensity running, dynamic mobility exercises, and progressive acceleration runs.

Sponsors

Pamukkale University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

All participants are assigned to a single study group and complete the same 8 × 30 m repeated sprint exercise protocol. Physiological, muscle oxygenation, cardiac autonomic, and neuromuscular responses are assessed before and at predefined time points after the exercise protocol. No control or comparator group is included.

Eligibility

Sex/Gender
MALE
Age
18 Years to 26 Years
Healthy volunteers
Yes

Inclusion criteria

* Licensed male competitive soccer player * Age between 18 and 26 years * Regularly participating in soccer training within a club * Actively participating in official competitions * At least 4 years of soccer training experience * Physically able to complete the repeated sprint protocol * No acute injury or illness on the measurement day * Voluntary agreement to participate and provision of written informed consent

Exclusion criteria

* Acute lower-extremity injury * Acute illness on the measurement day * Inability to complete the repeated sprint protocol * Missing data at any required measurement time point * Failure to complete the 24-hour follow-up measurements

Design outcomes

Primary

MeasureTime frameDescription
Heart Rate Variability: RMSSDBaseline, 5 minutes, 30 minutes, and 24 hours after the repeated sprint protocol.RMSSD was calculated from 5-minute R-R interval recordings obtained using a Polar H10 chest strap and analyzed with Kubios HRV Standard software. RMSSD was expressed in milliseconds and used as an indicator of parasympathetic cardiac autonomic recovery.

Secondary

MeasureTime frameDescription
Baseline Muscle Oxygen SaturationImmediately before the repeated sprint protocol.Baseline muscle oxygen saturation (SmO2) was measured as a percentage using portable Moxy Monitor near-infrared spectroscopy sensors placed on the vastus lateralis and biceps femoris muscles of the dominant leg.
Minimum Muscle Oxygen SaturationDuring the 8 × 30 m repeated sprint protocol.The lowest muscle oxygen saturation (SmO2) value recorded during the repeated sprint protocol was determined separately for the vastus lateralis and biceps femoris muscles and expressed as a percentage.
Muscle Oxygen Desaturation DifferenceBaseline and during the 8 × 30 m repeated sprint protocol on Study Day 1.The muscle oxygen desaturation difference was calculated separately for the vastus lateralis and biceps femoris as baseline SmO2 minus minimum SmO2 and expressed in percentage points.
Thirty-Second Muscle Reoxygenation30 seconds after completion of the repeated sprint protocol.Muscle oxygen saturation was recorded 30 seconds after completion of the repeated sprint protocol using NIRS sensors placed on the vastus lateralis and biceps femoris muscles and expressed as a percentage.
Muscle Reoxygenation RateDuring the first 30 seconds after completion of the repeated sprint protocol.Muscle reoxygenation rate was calculated separately for the vastus lateralis and biceps femoris using the formula \[(30-second reoxygenation SmO2 minus minimum SmO2) / 30\] and expressed as percentage points per second.
Countermovement Jump HeightBaseline, 10 minutes after the repeated sprint protocol, and 24 hours after the protocol.Countermovement jump height was measured in centimeters using the My Jump 2 smartphone application. Three valid trials were performed at each time point, and the best valid trial was used for analysis.
Blood Lactate ConcentrationImmediately before and 3 minutes after the repeated sprint protocol.Blood lactate concentration was measured in mmol/L using a Lactate Plus portable analyzer with capillary blood samples obtained from the fingertip.
Rating of Perceived ExertionImmediately after completion of the repeated sprint protocol.Perceived exertion was assessed using the Borg CR10 scale ranging from 0 to 10, where higher values indicate greater perceived exercise intensity.
Sprint Time Across RepetitionsDuring each of the eight repetitions of the repeated sprint protocol on the test day.Completion time for each of the eight 30-m maximal sprints was recorded in seconds using a Witty wireless electronic timing gate system.
Best Sprint TimeDuring the 8 × 30 m repeated sprint protocol on the test day.The fastest completion time among the eight 30-m maximal sprint repetitions was recorded in seconds.
Mean Sprint TimeDuring the 8 × 30 m repeated sprint protocol on the test day.The arithmetic mean of the completion times recorded for the eight 30-m maximal sprint repetitions was calculated and expressed in seconds.
Total Sprint TimeDuring the 8 × 30 m repeated sprint protocol on the test day.The sum of the completion times recorded for all eight 30-m maximal sprint repetitions was calculated and expressed in seconds.
Sprint Performance DecrementCalculated from the eight sprint times recorded during the repeated sprint protocol on the test day.Sprint performance decrement was calculated as \[(total sprint time / (best sprint time × number of sprints)) - 1\] × 100. Higher values indicate a greater decline in repeated sprint performance.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATOREngin Güneş Atabaş, PhD

Pamukkale Üniversitesi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 4, 2026